{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:42:02Z","timestamp":1790786522655,"version":"4.1.0"},"reference-count":39,"publisher":"BMFH Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.12938\/bmfh.2022-066","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T22:10:41Z","timestamp":1680732641000},"page":"213-221","source":"Crossref","is-referenced-by-count":11,"title":["Effects of <i>Bifidobacterium longum<\/i> CLA8013 on bowel movement improvement: a placebo-controlled, randomized, double-blind study"],"prefix":"10.12938","volume":"42","author":[{"given":"Keisuke","family":"OKADA","sequence":"first","affiliation":[{"name":"R&D Center, Biofermin Pharmaceutical Co., Ltd., 7-3-4 Higashi-machi, Ibukidai, Nishi-ku, Kobe, Hyogo 651-2242, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"TAKAMI","sequence":"additional","affiliation":[{"name":"R&D Center, Biofermin Pharmaceutical Co., Ltd., 7-3-4 Higashi-machi, Ibukidai, Nishi-ku, Kobe, Hyogo 651-2242, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"MAKIZAKI","sequence":"additional","affiliation":[{"name":"R&D Center, Biofermin Pharmaceutical Co., Ltd., 7-3-4 Higashi-machi, Ibukidai, Nishi-ku, Kobe, Hyogo 651-2242, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"TANAKA","sequence":"additional","affiliation":[{"name":"R&D Center, Biofermin Pharmaceutical Co., Ltd., 7-3-4 Higashi-machi, Ibukidai, Nishi-ku, Kobe, Hyogo 651-2242, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"NAKAJIMA","sequence":"additional","affiliation":[{"name":"R&D Center, Biofermin Pharmaceutical Co., Ltd., 7-3-4 Higashi-machi, Ibukidai, Nishi-ku, Kobe, Hyogo 651-2242, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"OHNO","sequence":"additional","affiliation":[{"name":"R&D Center, Biofermin Pharmaceutical Co., Ltd., 7-3-4 Higashi-machi, Ibukidai, Nishi-ku, Kobe, Hyogo 651-2242, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"SAGAMI","sequence":"additional","affiliation":[{"name":"Shinagawa Season Terrace Health Care Clinic, 5F, Shinagawa Season Terrace, 1-2-70 Konan, Minato-ku, Tokyo 108-0075, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5076","reference":[{"key":"1","unstructured":"1. Food and Agriculture Organization of the United Nations, World Health Organization2001. Food and Agriculture Organization and World Health Organization expert consultation. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. C\u00f3rdoba, Argentina. Available at: https:\/\/www.fao.org\/3\/a0512e\/a0512e.pdf."},{"key":"2","unstructured":"2. Kligler B, Cohrssen A. 2008. Probiotics. Am Fam Physician 78: 1073\u20131078."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gonz\u00e1lez-Rodr\u00edguez I, Ruiz L, Gueimonde M, Margolles A, S\u00e1nchez B. 2013. Factors involved in the colonization and survival of bifidobacteria in the gastrointestinal tract. FEMS Microbiol Lett 340: 1\u201310.","DOI":"10.1111\/1574-6968.12056"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EMM, Sanders ME, Shamir R, Swann JR, Szajewska H, Vinderola G. 2021. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol 18: 649\u2013667.","DOI":"10.1038\/s41575-021-00440-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. De Almada CN, Almada CN, Martinez RCR, Sant\u2019Ana AS. 2016. Paraprobiotics: evidences on their ability to modify biological responses, inactivation methods and perspectives on their application in foods. Trends Food Sci Technol 58: 96\u2013114.","DOI":"10.1016\/j.tifs.2016.09.011"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kanauchi O, Andoh A, AbuBakar S, Yamamoto N. 2018. Probiotics and paraprobiotics in viral infection: clinical application and effects on the innate and acquired immune systems. Curr Pharm Des 24: 710\u2013717.","DOI":"10.2174\/1381612824666180116163411"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Saito Y, Mihara T, Maruyama K, Saito J, Ikeda M, Tomonaga A, Kumagai T. 2017. Effects of intake of Lactobacillus casei<\/i> subsp. casei<\/i> 327 on skin conditions: a randomized, double-blind, placebo-controlled, parallel-group study in women. Biosci Microbiota Food Health 36: 111\u2013120.","DOI":"10.12938\/bmfh.16-031"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Abenavoli L, Scarpellini E, Colica C, Boccuto L, Salehi B, Sharifi-Rad J, Aiello V, Romano B, De Lorenzo A, Izzo AA, Capasso R. 2019. Gut microbiota and obesity: a role for probiotics. Nutrients 11: 2690.","DOI":"10.3390\/nu11112690"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Dimidi E, Christodoulides S, Fragkos KC, Scott SM, Whelan K. 2014. The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 100: 1075\u20131084.","DOI":"10.3945\/ajcn.114.089151"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Fuyuki A, Higurashi T, Kessoku T, Ashikari K, Yoshihara T, Misawa N, Iwaki M, Kobayashi T, Ohkubo H, Yoneda M, Usuda H, Wada K, Nakajima A. 2021. Efficacy of Bifidobacterium bifidum<\/i> G9-1 in improving quality of life in patients with chronic constipation: a prospective intervention study. Biosci Microbiota Food Health 40: 105\u2013114.","DOI":"10.12938\/bmfh.2020-073"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Koirala S, Anal AK. 2021. Probiotics-based foods and beverages as future foods and their overall safety and regulatory claims. Future Foods 3: 100013.","DOI":"10.1016\/j.fufo.2021.100013"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wald A, Scarpignato C, Kamm MA, Mueller-Lissner S, Helfrich I, Schuijt C, Bubeck J, Limoni C, Petrini O. 2007. The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther 26: 227\u2013236.","DOI":"10.1111\/j.1365-2036.2007.03376.x"},{"key":"13","unstructured":"13. Suares NC, Ford AC. 2011. Diagnosis and treatment of irritable bowel syndrome. Discov Med 11: 425\u2013433."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Vazquez Roque M, Bouras EP. 2015. Epidemiology and management of chronic constipation in elderly patients. Clin Interv Aging 10: 919\u2013930.","DOI":"10.2147\/CIA.S54304"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Drossman DA, Chang L, Chey WD. 2016. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology 150: 1262\u20131279.e2.","DOI":"10.1053\/j.gastro.2016.02.032"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rao SS, Yu S, Fedewa A. 2015. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther 41: 1256\u20131270.","DOI":"10.1111\/apt.13167"},{"key":"17","first-page":"1","volume":"11","year":"2019","unstructured":"17. de Vries J, Le Bourgot C, Calame W, Respondek F. 2019. Effects of \u03b2-fructans fiber on bowel function: a systematic review and meta-analysis. Nutrients 11: 1\u201317.","journal-title":"Nutrients","ISSN":"https:\/\/id.crossref.org\/issn\/2072-6643","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Huang R, Ning H, Shen M, Li J, Zhang J, Chen X. 2017. Probiotics for the treatment of atopic dermatitis in children: a systematic review and meta-analysis of randomized controlled trials. Front Cell Infect Microbiol 7: 392.","DOI":"10.3389\/fcimb.2017.00392"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Agachan F, Chen T, Pfeifer J, Reissman P, Wexner SD. 1996. A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum 39: 681\u2013685.","DOI":"10.1007\/BF02056950"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Matsuda K, Akiyama T, Tsujibe S, Oki K, Gawad A, Fujimoto J. 2021. Direct measurement of stool consistency by texture analyzer and calculation of reference value in Belgian general population. Sci Rep 11: 2400.","DOI":"10.1038\/s41598-021-81783-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Jentsch TJ, Maritzen T, Zdebik AA. 2005. Chloride channel diseases resulting from impaired transepithelial transport or vesicular function. J Clin Invest 115: 2039\u20132046.","DOI":"10.1172\/JCI25470"},{"key":"22","unstructured":"22. Japan Patent JP2018-546380."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Tsunoda A, Yamada K, Takano M, Kusanagi H. 2016. The translation and validation of the Japanese version of the patient assessment of constipation quality of life scale. Surg Today 46: 414\u2013421.","DOI":"10.1007\/s00595-015-1179-2"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. 2006. Functional bowel disorders. Gastroenterology 130: 1480\u20131491.","DOI":"10.1053\/j.gastro.2005.11.061"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Lunsford TN, Harris LA. 2010. Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome. Int J Womens Health 2: 361\u2013374.","DOI":"10.2147\/IJWH.S4537"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Johanson JF, Ueno R. 2007. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety. Aliment Pharmacol Ther 25: 1351\u20131361.","DOI":"10.1111\/j.1365-2036.2007.03320.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Mishima E, Fukuda S, Shima H, Hirayama A, Akiyama Y, Takeuchi Y, Fukuda NN, Suzuki T, Suzuki C, Yuri A, Kikuchi K, Tomioka Y, Ito S, Soga T, Abe T. 2015. Alteration of the intestinal environment by lubiprostone is associated with amelioration of adenine-induced CKD. J Am Soc Nephrol 26: 1787\u20131794.","DOI":"10.1681\/ASN.2014060530"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Fukudo S, Hongo M, Kaneko H, Takano M, Ueno R. 2015. Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation. Clin Gastroenterol Hepatol 13: 294\u2013301.e5.","DOI":"10.1016\/j.cgh.2014.08.026"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ishiyama Y, Hoshide S, Mizuno H, Kario K. 2019. Constipation-induced pressor effects as triggers for cardiovascular events. J Clin Hypertens (Greenwich) 21: 421\u2013425.","DOI":"10.1111\/jch.13489"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. de la Loge C, Sullivan K, Pinkney R, Marquis P, Roux C, Meunier PJ. 2005. Cross-cultural validation and analysis of responsiveness of the QUALIOST: QUAlity of Life questionnaire In OSTeoporosis. Health Qual Life Outcomes 3: 69.","DOI":"10.1186\/1477-7525-3-69"},{"key":"31","unstructured":"31. Kira I.2013. Validity and reliability of a Japanese version of the patient assessment of constipation Quality of Life Questionnaire. J Jpn Soc Nurs Res 2: 119\u2013127."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. 2018. Effects of 28-day Bifidobacterium animalis<\/i> subsp. lactis<\/i> HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: a double-blind, randomized, placebo-controlled, and dose-ranging trial. Gut Microbes 9: 236\u2013251.","DOI":"10.1080\/19490976.2017.1412908"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Riezzo G, Orlando A, D\u2019Attoma B, Linsalata M, Martulli M, Russo F. 2018. Randomised double blind placebo controlled trial on Lactobacillus reuteri<\/i> DSM 17938: improvement in symptoms and bowel habit in functional constipation. Benef Microbes 9: 51\u201360.","DOI":"10.3920\/BM2017.0049"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kessoku T, Kobayashi T, Tanaka K, Yamamoto A, Takahashi K, Iwaki M, Ozaki A, Kasai Y, Nogami A, Honda Y, Ogawa Y, Kato S, Imajo K, Higurashi T, Hosono K, Yoneda M, Usuda H, Wada K, Saito S, Nakajima A. 2021. The role of leaky gut in nonalcoholic fatty liver disease: a novel therapeutic target. Int J Mol Sci 22: 1\u201314.","DOI":"10.3390\/ijms22158161"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Kano M, Masuoka N, Kaga C, Sugimoto S, Iizuka R, Manabe K, Sone T, Oeda K, Nonaka C, Miyazaki K, Ishikawa F. 2013. Consecutive intake of fermented milk containing Bifidobacterium breve<\/i> strain Yakult and galacto-oligosaccharides benefits skin condition in healthy adult women. Biosci Microbiota Food Health 32: 33\u201339.","DOI":"10.12938\/bmfh.32.33"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Mori N, Kano M, Masuoka N, Konno T, Suzuki Y, Miyazaki K, Ueki Y. 2016. Effect of probiotic and prebiotic fermented milk on skin and intestinal conditions in healthy young female students. Biosci Microbiota Food Health 35: 105\u2013112.","DOI":"10.12938\/bmfh.2015-022"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Silveira EA, Santos ASEAC, Ribeiro JN, Noll M, Dos Santos Rodrigues AP, de Oliveira C. 2021. Prevalence of constipation in adults with obesity class II and III and associated factors. BMC Gastroenterol 21: 217.","DOI":"10.1186\/s12876-021-01806-5"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Yun BY, Sim J, Yoon JH, Kim SK. 2022. Association between insomnia and constipation: a multicenter three-year cross-sectional study using shift workers\u2019 health check-up data. Saf Health Work 13: 240\u2013247.","DOI":"10.1016\/j.shaw.2022.01.001"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Lakhan SE, Kirchgessner A. 2010. Gut inflammation in chronic fatigue syndrome. Nutr Metab (Lond) 7: 79.","DOI":"10.1186\/1743-7075-7-79"}],"container-title":["Bioscience of Microbiota, Food and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bmfh\/42\/3\/42_2022-066\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T04:23:33Z","timestamp":1688185413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bmfh\/42\/3\/42_2022-066\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.12938\/bmfh.2022-066","relation":{},"ISSN":["2186-3342"],"issn-type":[{"value":"2186-3342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"2022-066"}}